Minnesota Bariatric Center

Minnesota Bariatric Center in Edina, MN operates under the medical direction of Dr. Lucian Panait, MD, a board-certified surgeon credentialed by the American Board of Surgery and a Fellow of the American College of Surgeons. The clinic holds Center of Excellence accreditation from the American Society for Metabolic and Bariatric Surgery, a designation that reflects adherence to rigorous standards in patient safety, surgical volume, and multidisciplinary care coordination. Dr. Panait's practice integrates both surgical bariatric procedures and medical weight management, allowing patients in the Twin Cities metro area to access a continuum of evidence-based obesity treatment options within a single care setting.

The center's non-surgical weight loss protocols feature three FDA-approved GLP-1 receptor agonists and dual incretin agonists: Liraglutide, Semaglutide, and Tirzepatide. Liraglutide is administered as a daily subcutaneous injection and works by slowing gastric emptying and enhancing satiety signaling in the hypothalamus. Semaglutide, available in weekly injection form, has demonstrated sustained weight reduction in clinical trials when combined with lifestyle modification. Tirzepatide represents a newer class of dual GIP/GLP-1 receptor agonists, offering enhanced glycemic control and weight loss efficacy for patients with obesity and comorbid type 2 diabetes. These peptide therapies are prescribed following comprehensive metabolic assessment, with dosing titrated according to individual tolerance and response. Patients receive structured follow-up to monitor efficacy, manage side effects, and adjust nutritional intake as body composition changes.

Dr. Panait's surgical expertise encompasses laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, and revisional bariatric procedures for patients who meet clinical criteria based on BMI, comorbidity burden, and prior weight loss attempts. His fellowship training in advanced minimally invasive techniques informs a surgical approach that prioritizes reduced recovery time and lower complication rates. The clinic's multidisciplinary model includes preoperative nutritional counseling, psychological evaluation, and postoperative support groups, ensuring that surgical candidates receive the behavioral and metabolic preparation necessary for long-term success. For patients who are not surgical candidates or prefer medical management, the peptide therapy programs offer an alternative pathway with regular provider contact and lab monitoring.

In-person consultations at the Edina location allow Dr. Panait to perform detailed physical examinations, review imaging and laboratory data, and discuss the risks and benefits of each treatment modality in the context of the patient's medical history. Initial visits typically include body composition analysis, metabolic panel review, and discussion of realistic weight loss timelines. Patients beginning peptide therapy receive injection training, dietary guidelines tailored to GLP-1 pharmacology, and a schedule for dose escalation. Follow-up appointments track weight trends, assess medication tolerance, and address emerging concerns such as nausea, constipation, or plateau phases. The clinic's protocols emphasize sustainable behavior change rather than rapid weight loss, with an understanding that obesity is a chronic disease requiring ongoing management.

Minnesota Bariatric Center's combination of surgical volume, Center of Excellence accreditation, and access to the latest peptide therapies positions it as a comprehensive resource for patients in Edina and surrounding Minnesota communities seeking medically supervised weight management. The clinic's focus on individualized treatment planning—whether through metabolic surgery, pharmacotherapy, or hybrid approaches—reflects an evidence-based philosophy that matches intervention intensity to patient need and preference. Dr. Panait's dual expertise in surgical and medical obesity treatment allows for flexible care pathways and the option to transition between modalities as clinical circumstances evolve.